Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
The Journal of Organic Chemistry|May 9, 2013
Additives promote Noyori-type reductions of a β-keto-γ-lactam: asymmetric syntheses of serotonin norepinephrine reuptake inhibitorsNicholas A Magnus, Bret A Astleford, Dana L T Laird, et al.The Journal of Organic Chemistry|June 4, 2005
Synthesis of a peroxime proliferator activated receptor (PPAR) alpha/gamma agonist via stereocontrolled Williamson ether synthesis and stereospecific SN2 reaction of S-2-chloro propionic acid with phenoxidesJames A Aikins, Michael Haurez, John R Rizzo, et al.Journal of Medicinal Chemistry|January 19, 2007
Synthesis and metabotropic glutamate receptor activity of S-oxidized variants of (-)-4-amino-2-thiabicyclo-[3.1.0]hexane-4,6-dicarboxylate: identification of potent, selective, and orally bioavailable agonists for mGlu2/3 receptorsJames A Monn, Steven M Massey, Matthew J Valli, et al.Journal of Pharmaceutical Sciences|March 18, 2014
Investigation of the mechanism of racemization of litronesib in aqueous solution: unexpected base-catalyzed inversion of a fully substituted carbon chiral centerSteven W Baertschi, Patrick J Jansen, Robert M Montgomery, et al.Journal of Medicinal Chemistry|May 3, 2002
Design and synthesis of a novel series of 1,2-disubstituted cyclopentanes as small, potent potentiators of 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid (AMPA) receptorsTimothy A Shepherd, James A Aikins, David Bleakman, et al.Journal of Medicinal Chemistry|May 17, 2013
Synthesis and pharmacological characterization of 4-substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates: identification of new potent and selective metabotropic glutamate 2/3 receptor agonistsJames A Monn, Matthew J Valli, Steven M Massey, et al.Journal of Medicinal Chemistry|October 29, 2009
Synthesis, crystallization, and biological evaluation of an orally active prodrug of gemcitabineDavid M Bender, Jingqi Bao, Anne H Dantzig, et al.Journal of Medicinal Chemistry|November 28, 2007
(S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptorMichael G Bell, Douglas L Gernert, Timothy A Grese, et al.Journal of Medicinal Chemistry|April 30, 2004
Design and synthesis of alpha-aryloxy-alpha-methylhydrocinnamic acids: a novel class of dual peroxisome proliferator-activated receptor alpha/gamma agonistsYanping Xu, Christopher J Rito, Garret J Etgen, et al.Journal of Medicinal Chemistry|April 13, 2016
Discovery of the First α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist Dependent upon Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8Kevin M Gardinier, Douglas L Gernert, Warren J Porter, et al.Pageof 3